Open Demo Account
Home / Market Update / A new drug from AstraZeneca against Corona passes the last stage of trials
AstraZeneca
AstraZeneca

A new drug from AstraZeneca against Corona passes the last stage of trials

Adel 11 October, 2021 12:36 pm Market Update

AstraZeneca Inc said on Monday that its antibody-mixture drug, the first protective dose other than vaccines against Covid-19, has achieved its main goals in last-stage trials by helping reduce severe cases of Covid-19 infection or death

Tags

Check Also

European Stocks Edge Higher as Markets Weigh Iran Risks, U.S. Inflation and Earnings Season

European equities traded mixed to slightly higher on Tuesday, as investors balanced a positive lead …

This site contains information and opinions for the purpose of providing only general information and can not be relied upon. The information and opinions contained in this Site shall in no way constitute an offer or solicitation to buy, sell or subscribe to any investment product. Users of this site shall bear any risks arising from the use of any information, opinion, program, service or material. Noor Trends reserves the right to make any change to the Site, the information, opinions, materials, products, programs, services or prices (if any) at any time without notice.
All copyrights reserved Noor Trends